Cargando…
Application of a disease-specific mapping function to estimate utility gains with effective treatment of schizophrenia
BACKGROUND: Most tools for estimating utilities use clinical trial data from general health status models, such as the 36-Item Short-Form Health Survey (SF-36). A disease-specific model may be more appropriate. The objective of this study was to apply a disease-specific utility mapping function for...
Autores principales: | Lenert, Leslie A, Rupnow, Marcia FT, Elnitsky, Christine |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1262745/ https://www.ncbi.nlm.nih.gov/pubmed/16153308 http://dx.doi.org/10.1186/1477-7525-3-57 |
Ejemplares similares
-
Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging
por: Bailey, Robert A, et al.
Publicado: (2014) -
Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: Data from a randomized double-blind trial
por: Gharabawi, Georges M, et al.
Publicado: (2006) -
Impact of hypoglycemia on patients with type 2 diabetes mellitus and their quality of life, work productivity, and medication adherence
por: Lopez, Janice MS, et al.
Publicado: (2014) -
Application of a Mapping Function to Estimate Utilities for Ragweed Allergy Immunotherapy Trials
por: Dick, Katherine, et al.
Publicado: (2020) -
Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients
por: Stokes, Michael E, et al.
Publicado: (2011)